TP53 and neoplasm: Horvath et al. expanded on these findings by demonstrating that p53 overexpression in mucosa indefinite for dysplasia predicted subsequent progression to neoplasia in 25% of patients, reinforcing its role as an early biomarker of malignant potential [30].